A study on safety of risk reducing mastectomy(RRM)

A study on safety of risk reducing mastectomy(RRM) - A study on safety of RRM

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000021531

Enrollment

Registered

2016-03-24

Start date

2014-04-24

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hereditary breast and ovarian cancer

Interventions

risk reducing mastectomy

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1.BRCA1/2 mutation carriers 2.Woman with breast cancer in present or the past 3.Woman who received genetic counseling 4.ECOG Performance Status=0 5.Informed consent

Exclusion criteria

Exclusion criteria: 1.Woman with unstable mental state 2.Pregnant or lactating woman 3.Woman with active overlap cancer 4.The case in which doctor does not approve to perform RRM.

Design outcomes

Primary

Measure	Time frame
Adverse event related to RRM during 3 months after RRM	—

Secondary

Measure	Time frame
Adverse event related to RRM between 3 months and 5 years after RRM	—

Countries

Japan

Contacts

Public ContactAkiyo Yoshimura

Aichi Cancer Center Hospital breast oncology

akiyo@aichi-cc.jp052-762-6111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026